Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 689 JPY -0.53% Market Closed
Market Cap: 613.5B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Santen Pharmaceutical Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Net Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Net Income
ÂĄ26.9B
CAGR 3-Years
51%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income
ÂĄ150.1B
CAGR 3-Years
-30%
CAGR 5-Years
71%
CAGR 10-Years
3%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income
ÂĄ295.3B
CAGR 3-Years
55%
CAGR 5-Years
21%
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Net Income
ÂĄ146B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Income
ÂĄ28.6B
CAGR 3-Years
-38%
CAGR 5-Years
-36%
CAGR 10-Years
-15%

See Also

What is Santen Pharmaceutical Co Ltd's Net Income?
Net Income
26.9B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Net Income amounts to 26.9B JPY.

What is Santen Pharmaceutical Co Ltd's Net Income growth rate?
Net Income CAGR 10Y
6%

The average annual Net Income growth rates for Santen Pharmaceutical Co Ltd have been 51% over the past three years , -3% over the past five years , and 6% over the past ten years .

Back to Top